ReviewSurgical neurology international2025
Tumefactive primary angiitis of the central nervous system mimicking glioblastoma: A case-based systematic review.
Review in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Overview of Primary Angiitis of the Central Nervous System: Current Insights.Archives of internal medicine research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary angiitis of the central nervous system (PACNS) is an uncommon inflammatory condition that affects small- to medium-sized central nervous system vessels. Diagnosis remains challenging owing to the nonspecific clinical and radiological characteristics that frequently reflect glioblastoma or other neurological disorders. This study presents a case of a solitary tumefactive PACNS lesion initially misdiagnosed as glioblastoma. We also conducted a systematic analysis to assess the diagnostic variability, clinical-radiological characteristics, and treatment outcome. Methods: A 42-year-old woman with a 20-year history of migraines presented with unusual headaches for 6 weeks. Magnetic resonance imaging (MRI) scan findings indicate a right parietal lesion diagnosed initially as glioblastoma. Following minicraniotomy and resection, histopathological examination revealed PACNS. A Preferred Reporting Items for Systematic Review and Meta-Analysis-guided systematic review of published cases from 2000 to 2023, identified 34 tumor-like PACNS cases that exhibited characteristics similar to glioblastoma. Demographic data, predictive diagnostic imaging factors, histology, and management were collected and examined. Results: The review revealed a mean age of 35.92 years (range: 5-68 years), with a nearly equal sex distribution. Common symptoms included focal neurological impairments (71%), seizures (26%), and headaches (19%). MRI revealed T2 hyperintense lesions (87% with edema), which were frequently misinterpreted as glioblastoma owing to mass effect (68%). Magnetic resonance angiography was insensitive (48% abnormal). Histopathology identified lymphocytic (81%) or granulomatous (16%) vasculitis. Steroids (100%) were used in combination with cyclophosphamide (61%) or mycophenolate (23%). Relapses occurred in 26% of the cases, whereas 74% responded to therapy. Delayed diagnosis was associated with persistent impairment (29%). Conclusion: Tumefactive PACNS lesions frequently exhibit radiographic characteristics similar to glioblastoma, necessitating histological confirmation for accurate diagnosis. Immunosuppression is effective; however, standardized protocols are lacking. Despite the improvement in MRI predictive factors, future studies should investigate blood and cerebrospinal fluid biomarkers, advanced imaging, and conduct multicenter trials to enhance the diagnosis and treatment of this rare condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.